Total Funding
8
13
Total FundingSeries A raised
Growth Score
-7 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
904459
gIcare Pharma is a Canada-based company that develops novel gastrointestinal drugs for unmet medical needs.
About the Company
Founded in 2011, gIcare Pharma Inc is a biopharmaceutical, start-up company, which develops novel gastrointestinal drugs. Led by a dynamic management highly experienced in gastroenteolorogy, the Company's intent is to develop innovative medicines which align with currently unmet medical needs. While innovation should be, above all, primarily
beneficial to patients, gIcare Pharma believes that any novel drug should also provide clinical benefits to physicians as well as pharmaco-economic advantages to third-party payers. gIcare's flagship drug candidate, GIC-1001, combines these multi-level benefits and is the best example of what innovation means to us.
